Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment

Human epidermal growth factor receptor 2 (HER2) status in breast cancer is routinely determined through immunohistochemistry (IHC) and/or in situ hybridisation (ISH) performed on whole tissue sections (WS). The purpose was to evaluate whether a gene protein assay (GPA) combining IHC with ISH, perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandén, Emma, Khazaei, Somayeh, Tryggvadottir, Helga, Borgquist, Signe, Isaksson, Karolin, Jirström, Karin, Jernström, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371653/
https://www.ncbi.nlm.nih.gov/pubmed/32080761
http://dx.doi.org/10.1007/s00428-020-02768-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371653/
https://www.ncbi.nlm.nih.gov/pubmed/32080761
http://dx.doi.org/10.1007/s00428-020-02768-x

Ejemplares similares